Gtmetabolic
2 known investors
GT Metabolic develops magnetic compression anastomosis technology, including its MagDI System, which uses magnets to create incisionless, sutureless duodeno-ileal anastomoses during bariatric surgery. The technique is intended to support weight loss and glycemic control in obese patients with or without type 2 diabetes, and its products have received FDA marketing authorization and clearances.
HardwareHealthtechMedical Devices
Founders & leadership
TT
Thierry Thaurein
Investors · 2
Frequently asked questions
- What does Gtmetabolic do?
- GT Metabolic develops magnetic compression anastomosis technology, including its MagDI System, which uses magnets to create incisionless, sutureless duodeno-ileal anastomoses during bariatric surgery. The technique is intended to support weight loss and glycemic control in obese patients with or without type 2 diabetes, and its products have received FDA marketing authorization and clearances.
- Who are Gtmetabolic's investors?
- Gtmetabolic's investors include Healthtech Capital, Krillion Ventures.